M. Wyllie

发表

Critical assessment of noradrenaline uptake in synaptosomal preparations

M. Wood, M. Wyllie, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

A reassessment of the binding of [3H]rauwolscine to membranes from the rat cortex

M. Wyllie, A. Broadhurst, 1986, Neuropharmacology.

Is there a common, high-affinity opioid binding site in rat brain?

M. Wood, M. Wyllie, A. Broadhurst, 1986, Journal of receptor research.

Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site—I Inhibition by drugs

M. Wood, M. Wyllie, A. Broadhurst, 1986, Neuropharmacology.

Assessment of Noradrenaline and 5‐Hydroxytryptamine Uptake in Intact Rat Brain

M. Wood, M. Wyllie, P. Moser, 1985, Journal of neurochemistry.

Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat

M. Wood, M. Wyllie, A. Broadhurst, 1984, Neuropharmacology.

Alpha 1-adrenoceptor subtypes in the human prostate.

C. Chapple, M. Wyllie, P. Greengrass, 1994, British journal of urology.

Abstracts, Poster Session

A. Zlotta, O. Rampin, J. Sullivan, 1999, European Urology.

Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies

M. Wyllie, M. Wyllie, 2003, BJU international.

Comprehensive analysis of clinical trials data shows unequivocally that Phosphodiesterase Inhibitors (PDEi) improve orgasm. The power of meta‐analysis?

M. Wyllie, Mike Wyllie, 2013, BJU international.

Na+, K+-ATPase activity and noradrenaline turnover in brown adipose tissue of rats exhibiting diet-induced thermogenesis.

N. Rothwell, M. Stock, M. Wyllie, 1981, Biochemical pharmacology.

Prostatic alpha 1-adrenoceptors and uroselectivity.

H. Lepor, K. Andersson, M. Wyllie, 1997, The Prostate.

Transforming growth factor β1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin

G. Yang, T. Timme, T. Thompson, 1997, The Prostate.

The involvement of potassium channels in the action of ciclazindol in rat portal vein

D. Criddle, G. Edwards, A. Weston, 1992, British journal of pharmacology.

Catecholamine and Thyroid Hormone Influence on Brown Fat Na+, K+-ATPase Activity and Thermogenesis in the Rat

N. Rothwell, M. Stock, M. Wyllie, 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Dopaminergic mechanisms in diet-induced thermogenesis and brown adipose tissue metabolism.

N. Rothwell, M. Stock, M. Wyllie, 1982, European journal of pharmacology.

Adenosinetriphosphate conservation by indoramin and other drugs.

M. Wyllie, P. Paciorek, J. F. Waterfall, 1981, Biochemical pharmacology.

The underlying pathophysiology and causes of erectile dysfunction.

M. Wyllie, 2005, Clinical cornerstone.

The long‐term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone‐deficient men

W. Dinsmore, M. Wyllie, 2012, BJU international.

Subcellular Site of Action of Imipramine in Rodent Brain

M. Wood, M. Wyllie, 1986, Journal of neurochemistry.

Blood pressure and urologists: like oil and water?

M. Wyllie, 2004, BJU international.

Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro

J. Masters, J. Masters, M. Wyllie, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Evaluation of the Sexual Assessment Monitor, a diagnostic device used to electronically quantify ejaculatory latency time: findings from three studies

D. Ralph, W. Dinsmore, K. Wylie, 2006, BJU international.

Influence of chronic administration of ciclazindol on energy balance and brown adipose tissue in adult 'cafeteria'-fed rats.

N. Rothwell, M. Stock, M. Wyllie, 1983, Journal of autonomic pharmacology.

Modulation of central noradrenaline release by postsynaptic receptors

M. Wood, M. Wyllie, J. Pheysey, 1982, The Journal of pharmacy and pharmacology.

Textbook of Erectile Dysfunction

I. Goldstein, R. Kirby, C. Carson, 1999 .

Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue

M. Wyllie, A. Giraldi, G. Wagner, 2000, International Journal of Impotence Research.

6.24 – Incontinence (Benign Prostatic Hyperplasia/Prostate Dysfunction)

M. Wyllie, S. Phillips, 2007 .

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

M. Wyllie, F. K. Habib, 2004, Prostate Cancer and Prostatic Diseases.

SYMPATHETIC MECHANISMS IN DIET‐INDUCED THERMOGENESIS: MODIFICATION BY CICLAZINDOL AND ANORECTIC DRUGS

N. Rothwell, M. Stock, M. Wyllie, 1981, British journal of pharmacology.

Disposition and pharmacokinetics of meptazinol in the CSF. Studies after intrathecal administration in the non-human primate Erythrocebus patas.

M. Wyllie, A. Dhiri, J. Sanford, 1987, British journal of anaesthesia.

A review of the current status of topical treatments for premature ejaculation

M. Wyllie, A. Morales, J. Barada, 2007, BJU international.

The role of local anaesthetics in premature ejaculation

M. Wyllie, J. A. Powell, Michael G. Wyllie, 2012, BJU international.

Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol‐delivery form of lidocaine‐prilocaine for treating premature ejaculation

G. Hackett, D. Goldmeier, W. Dinsmore, 2007, BJU international.

EFFECTS OF ANTICONVULSANT AND CONVULSANT DRUGS ON THE ATPASE ACTIVITIES OF SYNAPTOSOMES AND THEIR COMPONENTS

M. Wyllie, J. Gilbert, M.G. WYLLIE, 1976, British journal of pharmacology.

THE RELATIONSHIP BETWEEN NERVE TERMINAL ADENOSINE TRIPHOSPHATASES AND NEUROTRANSMITTER RELEASE: AS DETERMINED BY THE USE OF ANTIDEPRESSANT AND OTHER CNS‐ACTIVE DRUGS

Jean Charles Gilbert, M. Wyllie, J. Gilbert, 1980, British journal of pharmacology.

Prostatic α1‐adrenoceptors and uroselectivity

M. Wyllie, K. Andersson, H. Lepor, 1997 .

Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

M. Wyllie, P. Greengrass, A. Naylor, 1994, Urology.

Does doxazosin affect prostatic growth?

M. Wyllie, 1998, The Prostate.

Standards for clinical trials in male sexual dysfunctions.

A. Melman, H. Porst, A. Seftel, 2010, The journal of sexual medicine.

Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome

J. Nickel, R. Moldwin, M. Wyllie, 2009, BJU international.

Restoration of mean arterial pressure in endotoxic shock by meptazinol. Contributions from lysosomal membrane stabilisation, opiate antagonism and noradrenaline release.

M. Wyllie, P. Paciorek, M. H. Todd, 1983, Biochemical pharmacology.

A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats.

M. Wyllie, A. Ramage, Michael G. Wyllie, 1995, European journal of pharmacology.

Pharmacological properties of the cloned α1A/D‐adrenoceptor subtype are consistent with the α1A‐adrenoceptor characterized in rat cerebral cortex and vas deferens

M. Wyllie, P. Greengrass, A. Naylor, 1994 .

Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.

M. Wyllie, P. Greengrass, A. Naylor, 1994, British journal of pharmacology.

‘Up and coming’ treatments for premature ejaculation: progress towards an approved therapy

M. Wyllie, J. A. Powell, 2009, International Journal of Impotence Research.

TEMPE: Topical Eutectic-Like Mixture for Premature Ejaculation

M. Wyllie, A. Morales, R. Henry, 2008, Expert opinion on drug delivery.

PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study

M. Wyllie, W. Dinsmore, 2009, BJU international.

Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction

W. Dinsmore, M. Wyllie, W. Dinsmore, 2008, BJU international.

Changes in Central 5-Hydroxytryptamine Turnover Induced by Acute and Chronic Inhibition of the Re-Uptake Process

M. Wood, M. Wyllie, G. Diggory, 1981 .

INDUCED BY ACUTE AND CHRONIC INHIBITION OF THE

M. Wood, M. Wyllie, G. Diggory, 1981 .

Proceedings: Synaptic vesicle magnesium-adenosine triphosphatase as a possible site of action of anticonvulsant drugs.

M. Wyllie, J. Gilbert, 1975, British journal of pharmacology.

Medical Writing

M. Wyllie, 2004, BJU international.

M. Wyllie, 2004 .

The National Institutes of Health (NIH)‐sponsored MTOPS study showed

M. Wyllie, 2003 .

Effects of prostaglandins on the ATPase activities of synaptosomes.

M. Wyllie, J. Gilbert, 1975, Biochemical pharmacology.

Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.

C. Carson, M. Wyllie, 2010, The journal of sexual medicine.

81st (Spring) Meeting of Ulster Society of Internal Medicine, Friday 15th May 2009

M. Daly, A. Adgey, W. Dinsmore, 2009, The Ulster Medical Journal.

Effects of histamine antagonists on noradrenaline-stimulated blood flow and oxygen consumption of brown adipose tissue in the rat

N. Rothwell, M. Stock, M. Wyllie, 1984, Pflügers Archiv.

Left to Our Own Devices

Johan Redström, M. Wyllie, Michael G Wyllie, 2007, Music Composition in the 21st Century.

Is it worth the wait?

M. Wyllie, Mike G Wyllie, 2009, BJU international.

MONOTHERAPY FOR COMORBID ERECTILE DYSFUNCTION AND LOWER URINARY TRACT SYMPTOMS: PHOSPHODIESTERASE INHIBITOR OR α‐ADRENOCEPTOR ANTAGONIST?

M. Wyllie, 2012, BJU international.

Standards for clinical trials in sexual dysfunctions of women: research designs and outcomes assessment.

J. Hyde, R. Segraves, J. Heiman, 2004, The journal of sexual medicine.

Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industry.

H. Lepor, M. Wyllie, J. C. McGrath, 1996, Urology.

Section Review Central & Peripheral Nervous Systems: α1-Adrenoceptor antagonists as treatments for benign prostatic hyperplasia

M. Wyllie, A. Naylor, A. Collis, 1995 .

Nerve terminal ATPase as possible trigger for neurotransmitter release

J. Gilbert, M. Wyllie, MICHAEL G. WYLLIE, 1975, Nature.

Another year, another AUA

M. Wyllie, 2006, BJU international.

013 Description of a Patient Reported Outcome approved by FDA for use in Phase III studies in Premature Ejaculation

M. Wyllie, 2018 .

Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for ‘on‐demand’ treatment of premature ejaculation

J. Mulhall, K. Andersson, M. Wyllie, 2006, BJU international.

Pharmacology of drugs used in premature ejaculation

M. Wyllie, 2016 .

The link between penile hypersensitivity and premature ejaculation

W. Hellstrom, M. Wyllie, 2011, BJU international.

ADAM and the andropause

M. Wyllie, 2003, BJU international.

Andropause on the move?

M. Wyllie, 2005, BJU International.

Libido and desire: join the club?

M. Wyllie, 2003, BJU international.

The role of alpha1D-adrenoceptors in prostatic contraction examined using protection studies.

R. Chess-Williams, C. Chapple, M. Wyllie, 2002, Autonomic & autacoid pharmacology.

Ebbing and flowing

M. Wyllie, 2007, BJU international.

Studies of the physiological roles of prostaglandins in the central nervous system

M. Wyllie, J. Gilbert, D. V. Davison, 1978, Neuropharmacology.

The rapid preparation of synaptosomes, using a vertical rotor.

M. Wood, M. Wyllie, 1981, Journal of Neurochemistry.

Resolution of monoamine uptake into binding and translocation components

M. Wood, M. Wyllie, 1982, Neuropharmacology.

α1-Adrenoceptor Selectivity: The North American Experience

M. Wyllie, 1999, European Urology.

Pharmacology and Pathology of the Lower Urinary Tract I. Benign Prostatic Hyperplasia (BPH)

M. Wyllie, 1999 .

Divided by more than a common language

M. Wyllie, 2016, BJU international.

EFFECTS OF Δ9‐TETRAHYDROCANNABINOL AND CANNABIDIOL ON A Mg2+‐ATPase OF SYNAPTIC VESICLES PREPARED FROM RAT CEREBRAL CORTEX

R. Pertwee, M. Wyllie, J. Gilbert, 1977 .

Peyronie’s disease: evaluation and review of non-surgical therapy Frederick L Taylor and Laurence A Levine

I. Goldstein, R. Kirby, C. Carson, 2008 .

alpha1-adrenoceptor selectivity: the North American experience.

M. Wyllie, 1999, European urology.

Proceedings: Effects of ethosuximide on adenosine triphosphatase activities of some subcellular fractions prepared from rat cerebral cortex.

M. Wyllie, A. Scott, J. Gilbert, 1974, British Journal of Pharmacology.

Inhibition of synaptosome ATPase by PGE1 may be dependent on a soluble factor [proceedings].

M. Wyllie, J. Gilbert, 1979, British journal of pharmacology.

Mythology and reality should never be confused (but often are)

M. Wyllie, 2017, BJU international.

Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculation.

F. Montorsi, S. Glina, M. Wyllie, 2004, The journal of sexual medicine.

The hunt for pink Viagra

M. Wyllie, 2005, BJU international.

Influence of Thyroid Hormone on Diet-Induced Thermogenesis in the Rat

N. Rothwell, M. Stock, M. Wyllie, 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.